Log in

Relevant bibliographies by topics / Systemic experience / Journal articles

To see the other types of publications on this topic, follow the link: Systemic experience.

Journal articles on the topic 'Systemic experience'

Author: Grafiati

Published: 13 April 2024

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Systemic experience.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Hildebrand, Judy, and Desa Markovic. "Systemic Therapists' Experience of Powerlessness." Australian and New Zealand Journal of Family Therapy 28, no. 04 (2007): 191–99. http://dx.doi.org/10.1375/anft.28.4.191.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Keashly, Loraleigh. "Interpersonal and Systemic Aspects of Emotional Abuse at Work: The Target’s Perspective." Violence and Victims 16, no. 3 (2001): 233–68. http://dx.doi.org/10.1891/0886-6708.16.3.233.

Full text

Abstract:

The most frequent form of workplace aggression is not physical, it is emotional and psychological in nature. Known by many names, emotional abuse at work is rapidly becoming recognized as pervasive and costly both in individual and organizational terms. Most of the research to date on emotional abuse at work has utilized survey and other quantitative methodologies in an effort to document the presence, prevalence, and impact of these behaviors. However, these methodologies are based on researchers’ definitions and theories of what constitutes emotional abuse rather than on the meaning given to these experiences by the targets of these behaviors. A thorough understanding of this phenomenon requires a scholarly appreciation of the target’s experience. Taking “feeling abused” as the criterion variable, this study examined target’s experiences based on interviews with people who self-identifed as having experienced difficulties with a boss, coworker, or subordinate. The interpersonal aspects of emotional abuse focused on the nature of behaviors exhibited and the respondents’ labeling of their experience. Consistent with elements of researchers’ definitions, behaviors were defined as abusive when they were repetitive, resulted in injury or harm to target, and were experienced as a lack of recognition of the individual’s integrity. Judgments of violation of standards of conduct and unsolicited nature of the behaviors were also related to respondents’ experiences. Relative power differential was also an important element. However, contrary to researchers’ definitions, actor intent was not central in defining the experience as abusive. The systemic aspect of emotional abuse was illustrated in the nature of organizational responding to concerns raised by respondents. These responses were of critical importance in respondents’ labeling of their experiences as abusive. The focus on the meaning of the behaviors for the respondents provides an enriched picture of key definitional elements. Implications of the findings for future research are discussed.

APA, Harvard, Vancouver, ISO, and other styles

3

Strizhakov A, Strizhakov A N., Ignatko I V. Ignatko I, Bogomazova I. M. Bogomazova, et al. "Successful experience with systemic thrombolysis during pregnancy." Akusherstvo i ginekologiia 9_2021 (September 23, 2021): 222–26. http://dx.doi.org/10.18565/aig.2021.9.222-226.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Bahrami, Simin, Steven S. Raman, Steven Sauk, et al. "Ten-Year Experience With Nephrogenic Systemic Fibrosis." Journal of Computer Assisted Tomography 33, no. 6 (2009): 819–23. http://dx.doi.org/10.1097/rct.0b013e31819d68ed.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Galluccio, F., U. A. Walker, S. Nihtyanova, et al. "Registries in systemic sclerosis: a worldwide experience." Rheumatology 50, no. 1 (2010): 60–68. http://dx.doi.org/10.1093/rheumatology/keq355.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Sridhara, S., J. H. Butterfield, and C. R. Weiler. "Systemic Mastocytosis: Mayo clinic experience since 2000." Journal of Allergy and Clinical Immunology 127, no. 2 (2011): AB251. http://dx.doi.org/10.1016/j.jaci.2010.12.1000.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Viviani, Maria Anna, Anna Maria Tortorano, Antonio Pagano, et al. "European experience with itraconazole in systemic mycoses." Journal of the American Academy of Dermatology 23, no. 3 (1990): 587–93. http://dx.doi.org/10.1016/0190-9622(90)70260-o.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Saketkoo, Lesley Ann, Jessica K. Gordon, Kim Fligelstone, et al. "Patient Experience of Systemic Sclerosis–Related Calcinosis." Rheumatic Disease Clinics of North America 49, no. 2 (2023): 463–81. http://dx.doi.org/10.1016/j.rdc.2023.01.017.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Soleau, Scott W., Richard Schmidt, Steve Stevens, Anne Osborn, and Joel D. MacDonald. "Extensive Experience with Dural Sinus Thrombosis." Neurosurgery 52, no. 3 (2003): 534–44. http://dx.doi.org/10.1227/01.neu.0000047815.21786.c1.

Full text

Abstract:

Abstract OBJECTIVE Dural sinus thrombosis (DST) is an uncommon cause of stroke. The safest and most effective therapy for DST has not been conclusively identified. METHODS A retrospective chart review of data for 31 patients who were treated for DST at our institution between 1992 and 2001 was performed. Four treatment strategies were identified, i.e., 1) medical observation only, 2) systemic anticoagulation (AC) therapy with heparin, 3) endovascular chemical thrombolysis with urokinase or tissue plasminogen activator and concurrent systemic AC therapy, and 4) mechanical endovascular clot thrombolysis with concurrent systemic AC therapy. Complications and clinical outcomes were assessed for each group. RESULTS Patients treated solely with medical observation fared the worst; four of five patients experienced intracranial hemorrhagic complications, and only two of five exhibited clinical improvement. Patients who received systemic AC therapy experienced no hemorrhagic complications, even when pretreatment hemorrhage was present; 75% (six of eight patients) exhibited improvement with AC therapy alone. Chemical thrombolysis was very effective in restoring sinus patency (90% of patients); however, 30% of patients (3 of 10 patients) experienced hemorrhagic complications. Sixty percent of patients (6 of 10 patients) who underwent chemical thrombolysis exhibited clinical improvement. Patients who underwent mechanical thrombectomies demonstrated a low hemorrhagic complication rate, and most (88%) made good recoveries. CONCLUSION Therapy directed at the underlying clot in DST must begin without delay. Our results suggest that supportive medical management of DST, without therapy directed at the clot or clotting process, is not effective. Systemic AC therapy, even in the presence of intracerebral hemorrhage, seems to be safe. Heparin can be safely titrated to yield partial thromboplastin times of 60 to 70 seconds. Chemical clot thrombolysis is efficacious in opening occluded sinuses but may cause intracranial hemorrhage. We currently recommend either systemic AC therapy or systemic AC therapy in conjunction with mechanical clot thrombectomy as a safe effective treatment for DST.

APA, Harvard, Vancouver, ISO, and other styles

10

Handlovsky, Ingrid, Vicky Bungay, John Oliffe, and Joy Johnson. "Developing Resilience: Gay Men’s Response to Systemic Discrimination." American Journal of Men's Health 12, no. 5 (2018): 1473–85. http://dx.doi.org/10.1177/1557988318768607.

Full text

Abstract:

Gay men experience marked health disparities compared to heterosexual men, associated with profound discrimination. Resilience as a concept has received growing attention to increase understanding about how gay men promote and protect their health in the presence of adversity. Missing in this literature are the perspectives and experiences of gay men over 40 years. This investigation, drawing on grounded theory methods, examined how gay men over 40 years of age develop resilience over the course of their lives to promote and protect their health. In-depth interviews were undertaken with 25 men ranging between 40 and 76 years of age who experienced an array of health concerns including depression, anxiety, suicidality, and HIV. Men actively resist discrimination via three interrelated protective processes that dynamically influence the development of resilience over their life course: (a) building and sustaining networks, (b) addressing mental health, and (c) advocating for respectful care encounters. Initiatives to promote and protect the health of gay men must be rooted in the recognition of the systemic role of discrimination, while supporting men’s resilience in actively resisting discrimination.

APA, Harvard, Vancouver, ISO, and other styles

11

Duguay, Cynthia, Frances Gallagher, and Martin Fortin. "The Experience of Adults with Multimorbidity: A Qualitative Study." Journal of Comorbidity 4, no. 1 (2014): 11–21. http://dx.doi.org/10.15256/joc.2014.4.31.

Full text

Abstract:

Background Findings from several countries indicate that the prevalence of multimorbidity is very high among clients of primary healthcare. A deeper understanding of patients’ experiences from their own perspective can greatly enrich any intervention to help them live as well as possible with multimorbidity. Objective To describe the fundamental structure of adults’ experience with multimorbidity. Design A phenomenological study was undertaken to describe the experiences of 11 adults with multimorbidity. These adults participated in two semi-structured interviews, the content of which was rigorously analyzed. Results At the core of the study participants’ multimorbidity experience are the impression of aging prematurely, difficulties with self-care management, and issues with access to the healthcare system, which contribute to the problem's complexity. Despite these issues, participants with multimorbidity report attempting to take control of their situation and adjusting to daily living. Conclusions The description of this experience, through the systemic vision of participants, provides a better understanding of the realities experienced by people with multimorbidity.

APA, Harvard, Vancouver, ISO, and other styles

12

Haghighi, AfshinBorhani, and ShahabGhasem Haza. "Neuropsychiatric manifestations of systemic lupus erythematosus: Iranian experience." Annals of Indian Academy of Neurology 13, no. 2 (2010): 108. http://dx.doi.org/10.4103/0972-2327.64633.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Boogaerts, Marc, and Johan Maertens. "Clinical Experience with Itraconazole in Systemic Fungal Infections." Drugs 61, Supplement 1 (2001): 39–47. http://dx.doi.org/10.2165/00003495-200161001-00004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Pannelier, C., A. Vienet, and E. Chwetzoff. "Itraconazole in Systemic Aspergillosis: Experience in 22 Cases." Chemotherapy 38, no. 1 (1992): 54. http://dx.doi.org/10.1159/000239074.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Lee, Han Chu. "Systemic Chemotherapy of Hepatocellular Carcinoma – Korean Experience." Oncology 75, no. 1 (2008): 114–18. http://dx.doi.org/10.1159/000173432.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Kostić Dedić, S., V. Cvijanović, D. Jovanović, et al. "Sensory-motor polyneuropathy in systemic amyloidosis - our experience." Clinical Neurophysiology 126, no. 9 (2015): e182. http://dx.doi.org/10.1016/j.clinph.2015.04.040.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Lanciano, E., E. Praino, C. Rotondo, M. Covelli, F. Iannone, and G. Lapadula. "AB0494 Systemic sclerosis and cancer risk: our experience." Annals of the Rheumatic Diseases 72, Suppl 3 (2013): A939.3—A940. http://dx.doi.org/10.1136/annrheumdis-2013-eular.2816.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Zaki, I. "Systemic therapy of atopic dermatitis -- experience in children." Journal of the European Academy of Dermatology and Venereology 5, no. 1 (1995): S181—S182. http://dx.doi.org/10.1016/0926-9959(95)96521-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Yosr, Boussoukaya, Thabet Maissa, Kouki Syrine, et al. "Systemic Lupus Erythematosus and Skin Damage: Patient’s Experience." Journal of Innovations in Medical Research 2, no. 7 (2023): 32–34. http://dx.doi.org/10.56397/jimr/2023.07.05.

Full text

Abstract:

Systemic lupus erythematosus (SLE) is a non-organ-specific autoimmune disease that affects young patients and women in particular. We describe a Cross-sectional study conducted in the internal medicine department of Farhat Hached University Hospital in Sousse, Tunisia. We interviewed 12 patients with SLE about what they know about SLE, their skin symptoms and the measures they take on a daily basis to protect themselves. The DLQI questionnaire was used to evaluate their dermatological quality of life using.

APA, Harvard, Vancouver, ISO, and other styles

20

Patel, Kalpesh, Abhishek Gugliani, and Dhwani Mehta. "Managing Rhino-cerebral Mucormycosis: Institutional Experience." Bengal Journal of Otolaryngology and Head Neck Surgery 27, no. 3 (2019): 240–42. http://dx.doi.org/10.47210/bjohns.2019.v27i3.15.

Full text

Abstract:

Introduction Rhinocerebral mucormycosis is a rapidly progressive life threatening opportunistic fungal disease and usually occurs in individuals with weakened immune system. It is caused by filamentous fungi of Mucorales from class Mucormycotina. After nasal inoculation, it usually spreads to orbit and brain. The common presenting complaints are purulent sinusitis, facial swelling, headache, complaints of vision or palatal ulceration. Despite the many recent advances in the diagnosis and management of mucormycosis, it still carries a high mortality rate.  Materials and methods Here we present our experience in managing 30 such cases of mucormycosis that presented to our department between June 2016 to June 2018.  Results All these patients were started on systemic antifungals with or without surgical debridement. The patients were followed up with repeated nasal endoscopies and imaging studies.  Conclusion Successful treatment of mucormycosis consists of aggressive repeated surgical debridement of necrotic tissue, systemic antifungal therapy and immediate control of underlying systemic diseases. Since there are no clear-cut guidelines, the treatment needs to be individualized on a case to case basis.

APA, Harvard, Vancouver, ISO, and other styles

21

Nicoloro-SantaBarbara, Jennifer, Fatima Scipione, Marcie Reeder, and Teresa Green. "The Five Dimensions of the Indolent Systemic Mastocytosis Patient Experience – Uncovering the "Real-world” Experience of Patients with Indolent Systemic Mastocytosis." Journal of Allergy and Clinical Immunology 153, no. 2 (2024): AB224. http://dx.doi.org/10.1016/j.jaci.2023.11.721.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Camm, Christian Fielder, Abhishek Joshi, Abigail Moore, et al. "Bullying in UK cardiology: a systemic problem requiring systemic solutions." Heart 108, no. 3 (2021): 212–18. http://dx.doi.org/10.1136/heartjnl-2021-319882.

Full text

Abstract:

ObjectivesBullying of trainee doctors has been shown to be associated with detrimental outcomes for both doctors and patients. However, there is limited evidence regarding the level of bullying of trainees within medical specialties.MethodsAn annual survey of UK cardiology trainees was conducted through the British Junior Cardiologists’ Association between 2017 and 2020 and asked questions about experiencing and witnessing bullying, and exposure to inappropriate language/behaviour in cardiology departments. Fisher’s exact tests and univariable logistic regression models were used to describe associations between trainee characteristics, and reports of bullying and inappropriate language/behaviour.ResultsOf 1358 trainees, bullying was reported by 152 (11%). Women had 55% higher odds of reporting being bullied (OR: 1.55 95% CI (1.08 to 2.21)). Non-UK medical school graduates were substantially more likely to be bullied (European Economic Area (EEA) OR: 2.22 (1.31 to 3.76), non-EEA/UK OR: 3.16 (2.13 to 4.68)) compared with those graduating from UK-based medical schools. Women were more likely than men to report sexist language (14% vs 4%, p<0.001). Non-UK medical school graduates were more likely to experience racist language (UK 1.5%, EEA 6%, other locations 7%, p=0.006). One-third of trainees (33%) reported at least one inappropriate behaviour with 8% reporting being shouted at or targeted with spontaneous anger. Consultants in cardiology (82%) and other specialties (70%) were most commonly implicated by those reporting bullying.DiscussionBullying and inappropriate language are commonly experienced by cardiology trainees and disproportionately affect women and those who attended non-UK medical schools. Consultants both in cardiology and other specialties are the most commonly reported perpetrators.

APA, Harvard, Vancouver, ISO, and other styles

23

Kneebone, Ian. "Stroke: Experience and adjustment." FPOP Bulletin: Psychology of Older People 1, no. 96 (2006): 7–8. http://dx.doi.org/10.53841/bpsfpop.2006.1.96.7.

Full text

Abstract:

This paper provides a brief overview of a symposium on stroke presented at the 26th PSIGE Annual Conference held at the University of Sussex in July, 2006. The principal conclusion from the discussion, arising from the papers presented, was that psychologists should be taking a broader (more holistic, systemic) approach to post-stroke adjustment.

APA, Harvard, Vancouver, ISO, and other styles

24

Santin, Chiara. "Rewilding systemic practice." Murmurations: Journal of Transformative Systemic Practice 4, no. 1 (2021): 13–31. http://dx.doi.org/10.28963/4.1.3.

Full text

Abstract:

This paper is written in the context of the current ecological crisis affecting physical and mental health, social, economic, and political contexts, at local and global levels which calls for the disruption of old ways of thinking, living and moving towards the future through collective action. One way of responding as a systemic and family psychotherapist, has been my experience of rewilding my systemic practice with individuals, couples, and families in the UK since taking therapy outdoors. I will offer some examples of ecotherapy as part of my own personal and professional journey in “coming home” through nature, becoming an outdoor designer of therapeutic space and a minimalist wild therapist. I invite us all to re-think and re-create a therapeutic space which, by its very essence, is wild, meaning boundaryless, infinitely spacious and unpredictable. It can open up opportunities for creativity, for using metaphors to explore meanings beyond words. Nature becomes not only the context in which I practice but my co-therapist or even the primary therapist. Together we can enrich the therapeutic process through moments of magic and facilitate change using a wild reflecting team. In my experience of ecotherapy, voices from the wild carry unique messages, for example, birdsong can provide unexpected voices, useful interruptions or disruptions that can enrich the therapeutic process. Such a wild reflecting team can also be a daring metaphor to welcome the unexpected and unfamiliar into our systemic practices and relationships, to include new emerging and marginalised perspectives which may bring us all more in touch with our wildness, lost indigenous ways of relating and shape our futures through collective action.

APA, Harvard, Vancouver, ISO, and other styles

25

Trischler, Jakob, Anita Zehrer, and Jessica Westman. "A designerly way of analyzing the customer experience." Journal of Services Marketing 32, no. 7 (2018): 805–19. http://dx.doi.org/10.1108/jsm-04-2017-0138.

Full text

Abstract:

Purpose The purpose of this paper is to evaluate the usability of different design methods in understanding the customer experience from a contextual and systemic standpoint. Design/methodology/approach Three design methods (i.e. personas, observations and collaborative service mapping) were applied to analyze customer experiences in two service settings. These methods’ usability was compared across the two settings. Findings Personas, as informed by phenomenological interviews, provide insights into the customer’s broader lifeworld context. These insights assist in connecting with and understanding the customer experience from a dyadic customer-firm perspective. The involvement of the customer in service mapping activities supports the validation of findings and gives access to experience dimensions beyond the immediate service setting. Research limitations/implications The analysis is limited to three design methods and is based on small samples. Future research should systematically review design methods to provide a basis for a more comprehensive evaluation. Practical implications To successfully capture the contextual and systemic nature of the customer experience, managers should apply interpretive approaches and actively involve selected customers as “experts of their experiences”. The study provides guidelines on how design methods can be combined and applied to a more holistic customer experience analysis. Originality/value The paper shows that design methods, when applied in a combined form, can support an analysis that captures both in-depth insights into the customer’s lifeworld and the complexity of value constellations.

APA, Harvard, Vancouver, ISO, and other styles

26

Ozili, Peterson K. "Non-performing loans in European systemic and non-systemic banks." Journal of Financial Economic Policy 12, no. 3 (2019): 409–24. http://dx.doi.org/10.1108/jfep-02-2019-0033.

Full text

Abstract:

Purpose The distinction between systemic banks (GSIBs) and non-systemic banks (non-GSIBs) is driven by policy reasons. This study aims to examine the behaviour of non-performing loans in European GSIBs and non-GSIBs from 2004 to 2013. Design/methodology/approach The author uses regression methodology to analyse the association between non-performing loans (NPLs) and the state of the economy. Findings The author finds that more profitable banks witness higher NPLs regardless of them being systemic or non-systemic. Secondly, GSIBs have fewer NPLs during economic booms and during periods of increased lending, while non-GSIBs experience higher NPLs during periods of increased lending. The author also observes that European non-GSIBs that exceed regulatory capital requirement also experience higher NPLs. In the post-crisis period, there is a significant and negative relationship between NPLs and the economic cycle for GSIBs in the post-financial crisis period and a significant and positive relationship between NPLs, loan supply and bank profitability for GSIBs in the post-financial crisis period; on the other hand, there is a significant and negative relationship between NPLs and regulatory capital ratios for non-GSIBs in the post-financial crisis period and a significant and positive relationship between NPLs and bank profitability for non-GSIBs in the post-financial crisis period. The findings have implications. Originality/value To the best of the author’s knowledge, the literature on the determinants of NPL has not empirically examined the behaviour of NPLs in European GSIBs and non-GSIBs. This paper examines this issue to provide insights to help policymakers and academics understand the peculiarities of NPLs in Europe.

APA, Harvard, Vancouver, ISO, and other styles

27

Hanauer, Stephen B. "Clinical Experience with Tixocortol Pivalate." Canadian Journal of Gastroenterology 2, no. 4 (1988): 156–58. http://dx.doi.org/10.1155/1988/819089.

Full text

Abstract:

Tixocortol pivalate, the 21-thiol derivative of hydrocortisone. is a newly synthesized steroid with topical anti-inflammatory properties but is devoid of systemic glucocorticoid and mineralocorticoid activities and toxicity. The mechanism of action appears to be similar to that of other corticosteroids with regard to steroid binding sites and prostaglandin biosynthesis, however. the disassociation between local and systemic effects is due to a 'first pass' liver metabolism and rapid transformation with in red blood cells. ln both open and controlled studies in patients with acute or recurrent distal colitis, clinical efficacy has been noted at doses of 250 mg to 1000 mg in 100 ml solution without an effect on scrum cortisol levels or blood chemistries. Tixocortol pivalate has consistently shown to be as effective as systemically absorbed steroids for the treatment of distal ulcerative colitis with out the undesirable effects associated with currently available steroid preparations.

APA, Harvard, Vancouver, ISO, and other styles

28

Almeida, Maria do Socorro Teixeira Moreira, Catarina Fernandes Pires, and Joao Vicente Moreira Almeida. "Lung in Systemic Lupus Erythematosus: A Single-Center Experience." OALib 09, no. 09 (2022): 1–9. http://dx.doi.org/10.4236/oalib.1109248.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Coriu, D., S. Badelita, R. Talmaci, et al. "Bortezomib in systemic AL amyloidosis: a single center experience." Amyloid 18, sup1 (2011): 148–50. http://dx.doi.org/10.3109/13506129.2011.574354055.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Sağ, Erdal, Berna Uzunoğlu, Fatma Bal, et al. "Systemic onset juvenile idiopathic arthritis: a single center experience." Turkish Journal of Pediatrics 61, no. 6 (2019): 852. http://dx.doi.org/10.24953/turkjped.2019.06.005.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

EMAD, Yasser, Tarek EL-GOHARY, Hisham MUSTAFA, Iman H. BASSYOUNI, and Noha A. AZAB. "Renal angiographic findings in systemic sclerosis: ?the Egyptian experience?" APLAR Journal of Rheumatology 10, no. 1 (2007): 43–48. http://dx.doi.org/10.1111/j.1479-8077.2007.00254.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Hartmann, A., H. Holdaas, P. Fauchald, et al. "Fifteen years' experience with renal transplantation in systemic amyloidosis." Transplant International 5, no. 1 (1992): 15–18. http://dx.doi.org/10.1111/j.1432-2277.1992.tb01716.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Pardeo, M., A. Insalaco, C. Bracaglia, et al. "P01-050 – Anakinra in systemic JIA: single center experience." Pediatric Rheumatology 11, Suppl 1 (2013): A53. http://dx.doi.org/10.1186/1546-0096-11-s1-a53.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Cocco, Annelise M., David Messer, Alexander Brown, et al. "Neoadjuvant systemic therapy for breast cancer: the Westmead experience." ANZ Journal of Surgery 88, no. 6 (2017): 640–44. http://dx.doi.org/10.1111/ans.14158.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Nair, Velu, Vivek Vasdev, Abhishek Kumar, Subramanian Shankar, Vivek Nair, and Ajay Sharma. "Stem cell transplant in systemic sclerosis: An Indian experience." International Journal of Rheumatic Diseases 21, no. 4 (2018): 859–65. http://dx.doi.org/10.1111/1756-185x.13262.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Ehrmann, Michael, and Paul Schure. "The European Systemic Risk Board – governance and early experience." Journal of Economic Policy Reform 23, no. 3 (2019): 290–308. http://dx.doi.org/10.1080/17487870.2019.1683011.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

LINDSLEY, CAROL B., and MICHAEL A. LINSHAW. "Systemic Lupus Erythematosus in Childhood: A 10-Year Experience." Pediatric Asthma, Allergy & Immunology 2, no. 4 (1988): 279–83. http://dx.doi.org/10.1089/pai.1988.2.279.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

CARABELLI, A., G. CROVETTI, M. GUIZZARDI, E. BERTANI, and E. BERTI. "P022 Extracorporeal photochemotherapy and systemic sclerosis: Our preliminary experience." Journal of the European Academy of Dermatology and Venereology 9 (September 1997): S158. http://dx.doi.org/10.1016/s0926-9959(97)89495-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Rangel-Guerra, Ricardo A., Héctor R. Martínez, Corando Sáenz, Francisco Bosques-Padilla, and Ingrid Estrada-Bellmann. "Rhinocerebral and systemic mucormycosis. Clinical experience with 36 cases." Journal of the Neurological Sciences 143, no. 1-2 (1996): 19–30. http://dx.doi.org/10.1016/s0022-510x(96)00148-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Pinn, M. E., D. G. Gold, I. A. Petersen, T. G. Osborn, P. D. Brown, and R. C. Miller. "Radiotherapy and Systemic Lupus Erythematosus: The Mayo Clinic Experience." International Journal of Radiation Oncology*Biology*Physics 69, no. 3 (2007): S544—S545. http://dx.doi.org/10.1016/j.ijrobp.2007.07.1793.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Wong, Priscilla H., Karla E. Adams, Geoffrey S. Carlson, and James M. Quinn. "Experience with Epinephrine Delivery in Immunotherapy-Associated Systemic Reactions." Journal of Allergy and Clinical Immunology 135, no. 2 (2015): AB214. http://dx.doi.org/10.1016/j.jaci.2014.12.1636.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Cabellos, C., J. M. Nolla, R. Verdaguer, et al. "Arthritis related to systemic meningococcal disease: 34 years’ experience." European Journal of Clinical Microbiology & Infectious Diseases 31, no. 10 (2012): 2661–66. http://dx.doi.org/10.1007/s10096-012-1610-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Pauling, John D., Lesley Ann Saketkoo, Marco Matucci-Cerinic, Francesca Ingegnoli, and Dinesh Khanna. "The patient experience of Raynaud’s phenomenon in systemic sclerosis." Rheumatology 58, no. 1 (2018): 18–26. http://dx.doi.org/10.1093/rheumatology/key026.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Bajracharya, Luna, and Surya Bahadur Thapa. "Childhood Systemic Lupus Erythematosus: A Tertiary Care Centre Experience." Journal of Nepal Paediatric Society 35, no. 2 (2016): 111–16. http://dx.doi.org/10.3126/jnps.v35i2.13282.

Full text

Abstract:

Introduction: Systemic lupus erythematosus (SLE) is a chronic immunologic disorder with multisystem manifestations. Even more awareness is required to diagnose the disease at younger age. Objective of this study was to explore clinico-laboratory manifestations and management of SLE in children at Tribhuvan University Teaching Hospital (TUTH).Materials and Methods: The study was retrospective hospital based study conducted from 15th July, 2008 to 14th July, 2014. Medical charts of all children and adolescent (6- 16years of age) with SLE admitted at TUTH were reviewed for analysis of data.Results: The total number of patients was 33, with 28(84.8%) girls and 5 (15.2%) boys. The mean age of diagnosis was 12.12 (SD 1.89). Facial puffiness (27.3%) and arthralgia (24.2%) were the commonest presentations at disease onset. The most frequent clinical features during the entire course of illness were edema (78.9%), anemia (69.7%) and fever (66.7%). Twenty three (69.6%) patients underwent renal biopsy in which class IV was the commonest lupus nephritis. The commonly used drugs after prednisolone were intravenous cyclophosphamide, intravenouse methylprednisolone and mycophenolate mofetil. Total 17 (51.5%) patients went into remission. Two patients died due to active lupus and four due to sepsis.Conclusion: Lupus nephritis was the commonest feature at disease onset, at the time of diagnosis and throughout the disease course among Nepalese children with SLE. The most frequently used medications were prednisolone and iv cyclophosphamide. Infection and active lupus were the leading causes of complications and death.J Nepal Paediatr Soc 2015;35(2):111-116

APA, Harvard, Vancouver, ISO, and other styles

45

Ul Azim, MuhammedArshad, Abdus Salam, and SkNishat Abdullah. "Experience of systemic lupus erythematosus in South-Western Bangladesh." Saudi Journal of Kidney Diseases and Transplantation 30, no. 3 (2019): 743. http://dx.doi.org/10.4103/1319-2442.261365.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Aseeva, E. A., S. K. Soloviev, A. A. Mesnyankina, M. E. Tsanyan, and E. L. Nasonov. "EXPERIENCE WITH BELIMUMAB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS." Rheumatology Science and Practice 53, no. 3 (2015): 329. http://dx.doi.org/10.14412/1995-4484-2015-329-335.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Wong, Priscilla H., Karla E. Adams, Geoffrey S. Carlson, and James M. Quinn. "Experience with epinephrine delivery in immunotherapy-associated systemic reactions." Annals of Allergy, Asthma & Immunology 116, no. 2 (2016): 166–68. http://dx.doi.org/10.1016/j.anai.2015.11.009.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Tselios, Konstantinos, Kristy Su-Ying Yap, Rattapol Pakchotanon, et al. "Psoriasis in systemic lupus erythematosus: a single-center experience." Clinical Rheumatology 36, no. 4 (2017): 879–84. http://dx.doi.org/10.1007/s10067-017-3566-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Almagro Torres, F., A. Baena Cubero, G. Garcia Fernandez, M. J. Martinez Quesada, J. A. Lopez Lopez, and M. S. Duran Nieto. "Primary Systemic Amyloidosis Associated With Multiple Myeloma. Our Experience." Clinical Lymphoma Myeloma and Leukemia 15 (September 2015): e206. http://dx.doi.org/10.1016/j.clml.2015.07.449.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Bawden, Richard. "Systemic development at Hawkesbury: some personal lessons from experience." Systems Research and Behavioral Science 22, no. 2 (2005): 151–64. http://dx.doi.org/10.1002/sres.682.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!